Morrison Research Group

Publications

2016

  • Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
    Yao YH, Cui Y, Qiu XN, Zhang LZ, Zhang W, Li H, Yu JM
    Chin J Cancer 2016, 35(1), 50

2015

  • Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 [CD44] and of Neuregulin-1 requires Substrate Dimerization.
    Hartmann M, Parra LM, Ruschel A, Lindner C, Morrison H, Herrlich** A, Herrlich** P
    J Biol Chem 2015, 290(28), 17041-54 ** co-senior authors, 2015 Best of jbc Papers of the Week Winner
  • Tumor suppressor NF2 blocks cellular migration by inhibiting ectodomain cleavage of CD44.
    Hartmann* M, Parra* LM, Ruschel A, Schubert S, Li Y, Morrison H, Herrlich** A, Herrlich** P
    Mol Cancer Res 2015, 13(5), 879-90 * equal contribution, ** co-senior authors
  • Deficiency of the protein-tyrosine phosphatase DEP-1/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells.
    Petermann A, Stampnik Y, Cui Y, Morrison H, Pachow D, Kliese N, Mawrin C, Böhmer FD
    J Neurooncol 2015, 122(3), 451-9
  • Inhibition of RAS Activation Due to a Homozygous Ezrin Variant in Patients with Profound Intellectual Disability.
    Riecken LB, Tawamie H, Dornblut C, Buchert R, Ismayel A, Schulz A, Schumacher J, Sticht H, Pohl KJ, Cui Y, Reis A, Morrison* H, Jamra* RA
    Hum Mutat 2015, 36(2), 270-8 * equal contribution
  • Small GTPase control by ERM proteins and their upstream regulator CPI-17 : implications for tumorigenesis
    Wiehl U
    Dissertation 2015, Jena, Germany
  • Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation.
    Zoch A, Mayerl S, Schulz A, Greither T, Frappart L, Rübsam J, Heuer H, Giovannini M, Morrison H
    PLoS One 2015, 10(8), e0129151
  • Merlin's wizardry guides cohesive migration.
    Zoch A, Morrison H
    Nat Cell Biol 2015, 17(3), 212-3

2014

  • Regulation of the NF2 tumour suppressor Merlin
    Jung J
    Dissertation 2014, Jena, Germany
  • Novel mechanism of JNK pathway activation by adenoviral E1A.
    Romanov* VS, Brichkina* AI, Morrison H, Pospelova TV, Pospelov VA, Herrlich P
    Oncotarget 2014, 5(8), 2176-86 * equal contribution